On Thursday, Cathie Wood-led Ark Invest made a series of trades, with the most prominent being the sale of Tesla Inc (NASDAQ:TSLA) shares.
The TSLA Trade
Earlier in July, Musk had endorsed Ark Invest’s $5 trillion valuation forecast for Tesla, suggesting it may be conservative. He cited the potential of the Optimus humanoid robot, estimating a global demand of over 20 billion units for both consumer and industrial applications.
Notably, in August, Ark Invest had unloaded $21million worth of Tesla stock.
See Also: Peter Schiff Warns Investors Against Keeping $20K In Cash: ‘One Of The Riskiest Bets You Can Make’
Other Key Trades:
Ark Invest’s ARKG ETF sold shares of Vertex Pharmaceuticals Inc (VRTX). Both ARKG and ARKK ETFs bought shares of CRISPR Therapeutics AG (CRSP).
Intellia Therapeutics Inc (NTLA) shares were also bought by ARKG and ARKK. ARKG bought shares of Cerus Corp (CERS). ARKK and ARKQ ETFs bought shares of Teradyne Inc (TER).
Read Next:
This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
